drugset / Trial / NCT03078803
Fecal Transplant for Crohn's Disease
Phase 2
Completed
38 enrolled
University of Alberta
McMaster University · collabUniversity of Calgary · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the efficacy and safety of serial FMT at inducing and maintaining clinical and endoscopic response in patients with mild to moderate Crohn's disease
Timeline
- Start
- 2017-03-28
- Primary completion
- 2021-06-21
- Completion
- 2022-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota Transplant | Other / unclassified | — | Other |